1. Home
  2. ZLAB vs HGV Comparison

ZLAB vs HGV Comparison

Compare ZLAB & HGV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • HGV
  • Stock Information
  • Founded
  • ZLAB 2013
  • HGV 1992
  • Country
  • ZLAB China
  • HGV United States
  • Employees
  • ZLAB N/A
  • HGV N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • HGV Hotels/Resorts
  • Sector
  • ZLAB Health Care
  • HGV Consumer Discretionary
  • Exchange
  • ZLAB Nasdaq
  • HGV Nasdaq
  • Market Cap
  • ZLAB 4.0B
  • HGV 4.0B
  • IPO Year
  • ZLAB 2017
  • HGV N/A
  • Fundamental
  • Price
  • ZLAB $33.34
  • HGV $46.71
  • Analyst Decision
  • ZLAB Buy
  • HGV Buy
  • Analyst Count
  • ZLAB 6
  • HGV 7
  • Target Price
  • ZLAB $57.22
  • HGV $51.29
  • AVG Volume (30 Days)
  • ZLAB 537.8K
  • HGV 1.1M
  • Earning Date
  • ZLAB 08-07-2025
  • HGV 07-31-2025
  • Dividend Yield
  • ZLAB N/A
  • HGV N/A
  • EPS Growth
  • ZLAB N/A
  • HGV N/A
  • EPS
  • ZLAB N/A
  • HGV 0.57
  • Revenue
  • ZLAB $427,799,000.00
  • HGV $4,478,000,000.00
  • Revenue This Year
  • ZLAB $42.62
  • HGV $15.79
  • Revenue Next Year
  • ZLAB $55.12
  • HGV $8.63
  • P/E Ratio
  • ZLAB N/A
  • HGV $82.06
  • Revenue Growth
  • ZLAB 32.56
  • HGV 12.43
  • 52 Week Low
  • ZLAB $18.91
  • HGV $30.59
  • 52 Week High
  • ZLAB $44.34
  • HGV $52.08
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 43.89
  • HGV 54.00
  • Support Level
  • ZLAB $31.79
  • HGV $42.84
  • Resistance Level
  • ZLAB $35.45
  • HGV $47.94
  • Average True Range (ATR)
  • ZLAB 1.00
  • HGV 1.30
  • MACD
  • ZLAB -0.22
  • HGV 0.28
  • Stochastic Oscillator
  • ZLAB 31.12
  • HGV 77.39

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About HGV Hilton Grand Vacations Inc.

Hilton Grand Vacations Inc is a timeshare company engaged in developing, marketing, selling, managing, and operating timeshare resorts, timeshare plans, and ancillary reservation services, under the Hilton Grand Vacations brand. The company operates business in the following two segments: (i) Real estate sales and financing and (ii) Resort operations and club management. The majority of the company's revenue is earned through the Real estate sales and financing segment, which generates revenue from VOI sales, and Financing.

Share on Social Networks: